The Pramodini Medicare IPO allotment has been finalised today, 17 August, according to reports from LiveMint. Investors who applied for the issue can check their allotment status through multiple official platforms including the NSE website and the registrar's portal, Purva Sharegistry India Pvt Ltd. The allotment process determines whether investors receive shares and the exact number of shares allocated to successful applicants based on their application details. As per NSE's official IPO allotment verification page, investors can access their status by selecting "Equity & SME IPO Bid Details" and entering their PAN No. and Application No. The subscription for the IPO closed on 14 August 2026, with the issue open for bidding from 12 August to 14 August 2026.
Refunds for non-allottees will begin on Tuesday, 18 August, as reported by LiveMint. Those who were not allocated shares will receive their refunds on this date, with the amount credited to their bank account linked to UPI. Conversely, investors who received shares will have their allotted shares credited to their demat accounts on the same day, Tuesday, 18 August. This timeline ensures all investors receive clear communication about their application status within 48 hours of the allotment announcement.
The Pramodini Medicare shares will be listed on NSE SME on Wednesday, 19 August, according to LiveMint reports. The listing follows the completion of the allotment process and refund procedures for non-allottees. After the listing, investors can track and invest in the stock directly through platforms like Kotak Neo. This timeline provides investors with a clear schedule for when their shares will become tradable on the exchange platform.
The Pramodini Medicare IPO GMP is ₹0, indicating shares are trading at the issue price of ₹118 with no premium or discount in the grey market, as reported by investorgain.com. This zero premium suggests investor sentiment remains neutral ahead of the listing, with no significant speculative interest in the shares. The grey market premium data as of 14 August 2026, 05:00 PM IST shows minimal movement across different investor categories.
The Pramodini Medicare IPO is a book-built SME issue worth ₹69.04 crore, comprising a fresh issue of 54 lakh shares and an offer for sale (OFS) of 5 lakh shares, according to LiveMint. The price band has been fixed at ₹110–₹118 per share. The company operates in the diagnostic services sector, offering radiology, clinical laboratory testing and nuclear medicine services through diagnostic centres across multiple states. As of August 4, 2026, the company operated 16 diagnostic centres across seven states, along with a 24×7 teleradiology unit and a processing laboratory in Vijayawada. The company was originally incorporated on September 12, 2000 as Pramodini Medicare Private Limited and changed to public limited company status on November 12, 2025. The minimum retail application size is 2,400 shares, while HNI investors must apply for at least 3,600 shares. The company intends to utilise net proceeds for funding capital expenditure for medical equipment purchases, general corporate purposes and unidentified inorganic acquisitions.
